TickerFacts.

RxSight, Inc. (RXST): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$19.34M
Year ended 2025-12-31
-$27.16M
Trailing 12 months to 2026-06-30
2020-12-31: -$37.74M2021-12-31: -$46.65M2022-12-31: -$61.24M2023-12-31: -$46.41M2024-12-31: -$22.39M2025-12-31: -$19.34M-$19.34M
2020-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$19.34Mn/m2026-02-25, From 2025-01-01
2024-12-31-$22.39Mn/m2026-02-25, From 2024-01-01
2023-12-31-$46.41Mn/m2026-02-25, From 2023-01-01
2022-12-31-$61.24Mn/m2025-02-25, From 2022-01-01
2021-12-31-$46.65Mn/m2023-03-06, From 2021-01-01
2020-12-31-$37.74Mn/a2022-03-08, From 2020-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
RxSight, Inc. (RXST)2025-12-31-$19.34Mn/m
Staar Surgical Co (STAA)2026-01-02-$40.05Mn/m
Warby Parker Inc. (WRBY)2025-12-31$43.74M+26.0%
National Vision Holdings, Inc. (EYE)2026-01-03$73.45M+92.6%
Cooper Companies, Inc. (COO)2025-10-31$433.70M+50.5%
Bausch & Lomb Corp (BLCO)2025-12-31-$66.00Mn/m
Innovative Eyewear Inc (LUCYW)2025-12-31-$7.35Mn/m

Compare RXST, STAA, WRBY, EYE side by side · Screen every company in Ophthalmic Goods ↗